Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2012 1
2014 1
2015 1
2016 1
2017 4
2018 6
2019 8
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for cbd thc synergistically
Your search for cbd thc synergisticly retrieved no results
An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia.
van de Donk T, Niesters M, Kowal MA, Olofsen E, Dahan A, van Velzen M. van de Donk T, et al. Pain. 2019 Apr;160(4):860-869. doi: 10.1097/j.pain.0000000000001464. Pain. 2019. PMID: 30585986 Free PMC article. Clinical Trial.
We tested 4 different cannabis varieties with exact knowledge on their [INCREMENT]-tetrahydrocannabinol (THC) and cannabidiol (CBD) content: Bedrocan (22.4-mg THC, <1-mg CBD; Bedrocan International BV, Veendam, the Netherlands), Bediol (13.4-mg T
We tested 4 different cannabis varieties with exact knowledge on their [INCREMENT]-tetrahydrocannabinol (THC) and cannabidiol (CBD
Single and combined effects of Δ9 -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain.
King KM, Myers AM, Soroka-Monzo AJ, Tuma RF, Tallarida RJ, Walker EA, Ward SJ. King KM, et al. Br J Pharmacol. 2017 Sep;174(17):2832-2841. doi: 10.1111/bph.13887. Epub 2017 Jul 27. Br J Pharmacol. 2017. PMID: 28548225 Free PMC article.
Oxaliplatin-treated (6.0 mg·kg(-1) i.p., day 1) or vincristine-treated mice (0.1 mg·kg(-1) i.p. days 1-7) were pretreated with CBD (1.25-10.0 mg·kg(-1) i.p.), THC (10.0 mg·kg(-1) i.p.) or THC + CBD (0.16 mg·kg(-1) THC + 0.16 mg·kg(-1) CBD
Oxaliplatin-treated (6.0 mg·kg(-1) i.p., day 1) or vincristine-treated mice (0.1 mg·kg(-1) i.p. days 1-7) were pretreated with CBD (1 …
Cannabis, from plant to pill.
Grof CPL. Grof CPL. Br J Clin Pharmacol. 2018 Nov;84(11):2463-2467. doi: 10.1111/bcp.13618. Epub 2018 May 24. Br J Clin Pharmacol. 2018. PMID: 29701252 Free PMC article. Review.
The cannabis plant has been described as a veritable 'treasure trove', producing more than 100 different cannabinoids, although the focus to date has been on the psychoactive molecule delta-9-tetraydrocannabinol (THC) and cannabidiol (CBD). ...Following supercritica …
The cannabis plant has been described as a veritable 'treasure trove', producing more than 100 different cannabinoids, although the focus to …
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.
Baron EP. Baron EP. Headache. 2018 Jul;58(7):1139-1186. doi: 10.1111/head.13345. Headache. 2018. PMID: 30152161 Review.
Most of the existing literature reports on the cannabinoids Δ(9) -tetrahydrocannabinol (THC) and cannabidiol (CBD), or cannabis in general. ...These components work synergistically to produce wide variations in benefits, side effects, and strain characteristi …
Most of the existing literature reports on the cannabinoids Δ(9) -tetrahydrocannabinol (THC) and cannabidiol (CBD), or cannabi …
Cannabis constituent synergy in a mouse neuropathic pain model.
Casey SL, Atwal N, Vaughan CW. Casey SL, et al. Pain. 2017 Dec;158(12):2452-2460. doi: 10.1097/j.pain.0000000000001051. Pain. 2017. PMID: 28885457
Only the high dose THC:CBD anti-allodynia was associated with cannabinoid side effects and these were similar to those of THC alone. Unlike THC, the low dose THC:CBD anti-allodynia was not cannabinoid receptor mediated. These findings dem …
Only the high dose THC:CBD anti-allodynia was associated with cannabinoid side effects and these were similar to those of T
A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.
Solowij N, Broyd S, Greenwood LM, van Hell H, Martelozzo D, Rueb K, Todd J, Liu Z, Galettis P, Martin J, Murray R, Jones A, Michie PT, Croft R. Solowij N, et al. Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):17-35. doi: 10.1007/s00406-019-00978-2. Epub 2019 Jan 19. Eur Arch Psychiatry Clin Neurosci. 2019. PMID: 30661105 Clinical Trial.
Two primary compounds within cannabis plant matter, Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD), are both psychoactive, but only THC is considered intoxicating. ...CBD showed some intoxicating properties relative to placebo. Low doses of C
Two primary compounds within cannabis plant matter, Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD), are both psychoacti …
Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
López-Valero I, Saiz-Ladera C, Torres S, Hernández-Tiedra S, García-Taboada E, Rodríguez-Fornés F, Barba M, Dávila D, Salvador-Tormo N, Guzmán M, Sepúlveda JM, Sánchez-Gómez P, Lorente M, Velasco G. López-Valero I, et al. Biochem Pharmacol. 2018 Nov;157:266-274. doi: 10.1016/j.bcp.2018.09.007. Epub 2018 Sep 7. Biochem Pharmacol. 2018. PMID: 30195736 Free article.
We also found that the administration of THC (or of THC + CBD at a 1:1 ratio) in combination with temozolomide (TMZ), the benchmark agent for the treatment of GBM, synergistically reduces the growth of glioma xenografts. ...Our findings show that TMZ + …
We also found that the administration of THC (or of THC + CBD at a 1:1 ratio) in combination with temozolomide (TMZ), t …
Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
Baron EP. Baron EP. Headache. 2015 Jun;55(6):885-916. doi: 10.1111/head.12570. Epub 2015 May 25. Headache. 2015. PMID: 26015168 Review.
Cannabinoids appear to modulate and interact at many pathways inherent to migraine, triptan mechanisms ofaction, and opiate pathways, suggesting potential synergistic or similar benefits. Modulation of the endocannabinoid system through agonism or antagonism of its recepto …
Cannabinoids appear to modulate and interact at many pathways inherent to migraine, triptan mechanisms ofaction, and opiate pathways, sugges …
Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration.
Nabissi M, Morelli MB, Offidani M, Amantini C, Gentili S, Soriani A, Cardinali C, Leoni P, Santoni G. Nabissi M, et al. Oncotarget. 2016 Nov 22;7(47):77543-77557. doi: 10.18632/oncotarget.12721. Oncotarget. 2016. PMID: 27769052 Free PMC article.
In other type of human cancers, the combination of CBD with Δ9-tetrahydrocannabinol (THC) was found to act synergistically with other chemotherapeutic drugs suggesting their use in combination therapy. In the current study, we evaluated the effects of THC
In other type of human cancers, the combination of CBD with Δ9-tetrahydrocannabinol (THC) was found to act synergistically
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort.
Baron EP, Lucas P, Eades J, Hogue O. Baron EP, et al. J Headache Pain. 2018 May 24;19(1):37. doi: 10.1186/s10194-018-0862-2. J Headache Pain. 2018. PMID: 29797104 Free PMC article.
Hybrid strains were preferred in ID Migraine™, headache, and most pain groups, with "OG Shark", a high THC (Δ9-tetrahydrocannabinol)/THCA (tetrahydrocannabinolic acid), low CBD (cannabidiol)/CBDA (cannabidiolic acid), strain with predominant terpenes β-caryophyllene …
Hybrid strains were preferred in ID Migraine™, headache, and most pain groups, with "OG Shark", a high THC (Δ9-tetrahydrocannabinol)/ …
24 results
Jump to page
Feedback